Skip to main content
. 2019 Jul 14;11(13):4338–4353. doi: 10.18632/aging.102052

Table 1. Details of 12 SLE patients.

Patient Age Disease duration Current treated SLEDAI
1 27 1 year Pred 12.5mg/day 4
HCQ 0.2g/day
CTX 0.4g/2 weeks
2 43 19 years Pred 10mg/day 8
HCQ 0.2g/day
CTX 0.4g/2 weeks
3 40 2 years Pred 15mg/day 4
HCQ 0.2g/day
4 23 3 years Pred 15mg/day 4
HCQ 0.2g/day
MTX 5mg/1 week
5 31 5 years Pred 7.5mg/day 1
6 26 9 years Pred 10mg/day 2
7 13 4 years Pred 12.5mg/day 11
HCQ 0.2g/day
8 25 5 years Pred 15mg/day 16
HCQ 0.2g/day
CTX 0.4g/2 weeks
9 25 8 years Pred 10mg/day 8
HCQ 0.2g/day
10 31 6 years Pred 15mg/day 8
HCQ 0.2g/day
11 35 7 years Pred 15mg/day 10
HCQ 0.2g/day
12 23 2 years none 5